Department of Urology, University Hospital Henri Mondor, APHP, Créteil, France.
INSERM Clinical Investigation Center 1430, Henri Mondor University Hospital, AP-HP, Créteil, France.
Sci Rep. 2022 Nov 8;12(1):18981. doi: 10.1038/s41598-022-22912-8.
We compared the outcomes of robotic-assisted partial nephrectomy (RPN) and open partial nephrectomy (OPN) using contemporary data to respond to unmet clinical needs. Data from patients included in the registry who underwent partial nephrectomy between January 01, 2014 and June 30, 2017 within 20 centres of the French Network for Research on Kidney Cancer UroCCR were collected (NCT03293563). Statistical methods included adjusted multivariable analyses. Rates of peri- and post-operative transfusion, and of surgical revision, were lower in the RPN (n = 1434) than the OPN (n = 571) group (2.9% vs. 6.0%, p = 0.0012; 3.8% vs. 11.5%, p < 0.0001; 2.4% vs. 6.7%, p < 0.0001, respectively). In multivariable analyses, RPN was independently associated with fewer early post-operative complications than OPN (overall: odds-ratio [95% confidence interval, CI] = 0.48 [0.35-0.66]; severe: 0.29 [0.16-0.54], p < 0.0001 for both) and shorter hospital stays (34% [30%; 37%], p < 0.0001). RPN was also a significantly associated with a decresedrisk of post-operative acute renal failure, and new-onset chronic kidney disease at 3 and 12 months post-surgery. There were no between-group differences in oncological outcomes. In comparison with OPN, RPN was associated with improved peri- and post-operative morbidity, better functional outcomes, and shorter hospital stays. Our results support the use of RPN, even for large and complex tumours.
我们比较了机器人辅助部分肾切除术(RPN)和开放部分肾切除术(OPN)的结果,使用了当代数据来应对未满足的临床需求。该研究的数据来自于 2014 年 1 月 1 日至 2017 年 6 月 30 日期间在法国肾癌研究网络 UroCCR 的 20 个中心接受部分肾切除术的患者(NCT03293563)。统计方法包括调整后的多变量分析。RPN 组(n=1434)的围手术期和术后输血以及手术修正率低于 OPN 组(n=571)(2.9%比 6.0%,p=0.0012;3.8%比 11.5%,p<0.0001;2.4%比 6.7%,p<0.0001)。多变量分析显示,与 OPN 相比,RPN 与较少的术后早期并发症独立相关(总体:优势比[95%置信区间,CI]为 0.48[0.35-0.66];严重并发症:0.29[0.16-0.54],p<0.0001),且住院时间更短(34%[30%-37%],p<0.0001)。RPN 还与术后急性肾功能衰竭和术后 3 个月和 12 个月新发慢性肾脏病的风险降低显著相关。两组之间在肿瘤学结果方面无差异。与 OPN 相比,RPN 与改善的围手术期发病率、更好的功能结果和更短的住院时间相关。我们的结果支持使用 RPN,即使是对于大型和复杂的肿瘤。